Prognostic role of D-dimer in patients with lung cancer: A meta-analysis

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 2103-2109

  Ma, Xuelei ^a   Li, Yanyan ^a   Zhang, Jing ^a   Huang, Jingwen ^a   Liu, Lei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

D dimer; Lung cancer; Overall survival; Prognostic value

Indexed keywords

D DIMER;

ARTICLE; CANCER PROGNOSIS; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; LUNG CANCER; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898845163     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1279-9     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Goad KE, Gralnick HR. Coagulation disorders in cancer. Hematol Oncol Clin North Am. 1996;10:457-84.
3. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113:2878-87.
4. Bick RL, Baker WF. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC). Thromb Res. 1992;65:785-90.
5. Gabazza E, Taguchi O, Yamakami T, Machishi M, Ibata H, et al. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer. Cancer. 1993;72:2134-40.
6. Buccheri G, Ferrigno D, Ginardi C, Zuliani C. Haemostatic abnormalities in lung cancer: prognostic implications. Eur J Cancer. 1997;33:50-5.
7. Green KB, Silverstein RL. Hypercoagulability in cancer. Hematol Oncol Clin North Am. 1996;10:499-530.
8. Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 2000;18:600-8.
9. Oya M, Akiyama Y, Okuyama T, Ishikawa H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001;31:388-94.
10. Unsal E, Atalay F, Atikcan S, Yilmaz A. Prognostic significance of hemostatic parameters in patients with lung cancer. Respir Med. 2004;98:93-8.
11. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835-46.
12. Rossi G, Rossi V. Deep vein thrombosis. Lancet. 2005;366:118-9. author reply 119-120.
13. Bick RL, Ucar K. Hypercoagulability and thrombosis. Hematol Oncol Clin North Am. 1992;6:1421-31.
14. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-34.
15. Williamson PR, Smith CT, Hutton JL, Marson AG. Aggregate data meta-analysis with time-to-event outcomes. Stat Med. 2002;21:3337-51.
16. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
18. Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol (R Coll Radiol). 2007;19:494-8.
19. Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97:1158-64.
20. Komurcuoglu B, Ulusoy S, Gayaf M, Guler A, Ozden E. Prognostic value of plasma D-dimer levels in lung carcinoma. Tumori. 2011;97:743-8.
21. Masago K, Fujita S, Mio T, Togashi Y, Kim YH, et al. Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer. Med Oncol. 2011;28:351-6.
22. Pavey SJ, Hawson GA, Marsh NA. Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma. Blood Coagul Fibrinolysis. 2001;12:51-8.
23. Taguchi O, Gabazza EC, Yasui H, Kobayashi T, Yoshida M, et al. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax. 1997;52:563-5.
24. Zhang PP, Sun JW, Wang XY, Liu XM, Li K. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism. Eur J Surg Oncol. 2013;39(9):951-6. doi: 10.1016/j.ejso.2013.06.008.
25. Wang Z, Fu J, Diao D, Dang C. Pre-operative plasma D-dimer level may predict the poor prognosis within one year after the surgery for non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2011;14:534-7.
26. Ferrigno D, Buccheri G, Ricca I. Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J. 2001;17:667-73.
27. Ursavaş A, Karadaǧ M, Uzaslan E, Yesilkaya S, Coşkun F, et al. Prognostic Significance of Plasma D-Dimer Levels in Patients with Lung Cancer Akciǧer Kanserli Hastalarda Plazma D-dimer Düzeylerinin Prognostik Deǧeri. Eur J Gen Med. 2010;7:155-60. 1304-3897.
28. Zhou YX, Yang ZM, Feng J, Shan YJ, Wang WL, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis. Tumour Biol. 2013. doi: 10.1007/s13277-013-0953-2.
29. Pawlotsky Y, Chales G, Coutard J, Meadeb J, Goasguen J, et al. Morning changes in the sigma ESR, erythrocyte sedimentation rate (Westergren) and C-reactive protein. Rev Rhum Mal Osteoartic. 1985;52:35-40.
30. Spruance SL, Reid JE, Grace M, Samore M. Hazard ratio in clinical trials. Antimicrob Agents Chemother. 2004;48:2787-92.
31. Hayes DC, Secrist H, Bangur CS, Wang T, Zhang X, et al. Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients. Anticancer Res. 2006;26:1567-75.
32. Dale S, Gogstad GO, Brosstad F, Godal HC, Holtlund J, et al. Comparison of three D-dimer assays for the diagnosis of DVT:ELISA, latex and an immunofiltration assay (NycoCard D-Dimer). Thromb Haemost. 1994;71:270-4.
33. Sijens PE, van Ingen HE, van Beek EJ, Berghout A, Oudkerk M. Rapid ELISA assay for plasma D-dimer in the diagnosis of segmental and subsegmental pulmonary embolism. A comparison with pulmonary angiography. Thromb Haemost. 2000;84:156-9.
34. Angchaisuksiri P, Atichartakarn V, Aryurachai K, Archararit N, Rachakom B, et al. Risk factors of venous thromboembolism in Thai patients. Int J Hematol. 2007;86:397-402.